Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as ...
Gallup data suggest GLP-1 injectables are already driving real changes in national obesity rates—even if diabetes still looms ...
New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...
Eli Lilly & Co. raised its full-year guidance as revenue from its blockbuster weight loss and diabetes drugs beat ...
People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and ...
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...
GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying ...
Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...
Mochi Health offers two subscription-based weight loss programs: Mochi Health and Wellness Plus. While anyone can access the ...
The heartbroken family of a mother-of-three who died after receiving a black market weight-loss injection has called for a ...
Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results